Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.
Identifieur interne : 001714 ( Main/Corpus ); précédent : 001713; suivant : 001715Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.
Auteurs : Tian Xia ; Yanfeng WangSource :
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [ 1600-6143 ] ; 2020.
English descriptors
- KwdEn :
- Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus (MeSH), Coronavirus Infections (drug therapy), Humans (MeSH), Hydroxychloroquine (MeSH), Lopinavir (MeSH), Pandemics (MeSH), Pneumonia, Viral (MeSH), Ritonavir (MeSH), SARS-CoV-2 (MeSH), Spain (MeSH), Tacrolimus (MeSH), Transplant Recipients (MeSH).
- MESH :
- chemical : Hydroxychloroquine, Lopinavir, Ritonavir, Tacrolimus.
- geographic : Spain.
- drug therapy : Coronavirus Infections.
- Betacoronavirus, COVID-19, Coronavirus, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2, Transplant Recipients.
DOI: 10.1111/ajt.15992
PubMed: 32400965
PubMed Central: PMC7273014
Links to Exploration step
pubmed:32400965Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.</title>
<author><name sortKey="Xia, Tian" sort="Xia, Tian" uniqKey="Xia T" first="Tian" last="Xia">Tian Xia</name>
<affiliation><nlm:affiliation>Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Yanfeng" sort="Wang, Yanfeng" uniqKey="Wang Y" first="Yanfeng" last="Wang">Yanfeng Wang</name>
<affiliation><nlm:affiliation>Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32400965</idno>
<idno type="pmid">32400965</idno>
<idno type="doi">10.1111/ajt.15992</idno>
<idno type="pmc">PMC7273014</idno>
<idno type="wicri:Area/Main/Corpus">001714</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001714</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.</title>
<author><name sortKey="Xia, Tian" sort="Xia, Tian" uniqKey="Xia T" first="Tian" last="Xia">Tian Xia</name>
<affiliation><nlm:affiliation>Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Yanfeng" sort="Wang, Yanfeng" uniqKey="Wang Y" first="Yanfeng" last="Wang">Yanfeng Wang</name>
<affiliation><nlm:affiliation>Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</title>
<idno type="eISSN">1600-6143</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (MeSH)</term>
<term>Lopinavir (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (MeSH)</term>
<term>Ritonavir (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Spain (MeSH)</term>
<term>Tacrolimus (MeSH)</term>
<term>Transplant Recipients (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Hydroxychloroquine</term>
<term>Lopinavir</term>
<term>Ritonavir</term>
<term>Tacrolimus</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Coronavirus</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
<term>SARS-CoV-2</term>
<term>Transplant Recipients</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32400965</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-6143</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>20</Volume>
<Issue>9</Issue>
<PubDate><Year>2020</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</Title>
<ISOAbbreviation>Am J Transplant</ISOAbbreviation>
</Journal>
<ArticleTitle>Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome.</ArticleTitle>
<Pagination><MedlinePgn>2630-2631</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/ajt.15992</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xia</LastName>
<ForeName>Tian</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Yanfeng</ForeName>
<Initials>Y</Initials>
<Identifier Source="ORCID">0000-0002-3859-0937</Identifier>
<AffiliationInfo><Affiliation>Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>81570079</GrantID>
<Agency>National Natural Science Foundation of China</Agency>
<Country>International</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Transplant</MedlineTA>
<NlmUniqueID>100968638</NlmUniqueID>
<ISSNLinking>1600-6135</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>2494G1JF75</RegistryNumber>
<NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>O3J8G9O825</RegistryNumber>
<NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>WM0HAQ4WNM</RegistryNumber>
<NameOfSubstance UI="D016559">Tacrolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Am J Transplant. 2020 Jul;20(7):1849-1858</RefSource>
<PMID Version="1">32301155</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017934" MajorTopicYN="Y">Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016559" MajorTopicYN="N">Tacrolimus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D066027" MajorTopicYN="N">Transplant Recipients</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">antibiotic: antiviral</Keyword>
<Keyword MajorTopicYN="Y">clinical research/practice</Keyword>
<Keyword MajorTopicYN="Y">complication: infectious</Keyword>
<Keyword MajorTopicYN="Y">drug interaction</Keyword>
<Keyword MajorTopicYN="Y">infectious disease</Keyword>
<Keyword MajorTopicYN="Y">kidney transplantation/nephrology</Keyword>
<Keyword MajorTopicYN="Y">liver transplantation/hepatology</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>05</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32400965</ArticleId>
<ArticleId IdType="doi">10.1111/ajt.15992</ArticleId>
<ArticleId IdType="pmc">PMC7273014</ArticleId>
</ArticleIdList>
<ReferenceList><Title>REFERENCES</Title>
<Reference><Citation>Fernández-Ruiz M, Andrés A, Loinaz C, et al. COVID-19 in solid organ transplant recipients: a single-center case series from Spain [published online ahead of print 2020]. Am J Transplant. 2020. https://doi.org/10.1111/ajt.15929</Citation>
</Reference>
<Reference><Citation>Bartiromo M, Borchi B, Botta A, et al. Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19) [published online ahead of print 2020]. Transpl Infect Dis. 2020. https://doi.org/10.1111/tid.13286</Citation>
</Reference>
<Reference><Citation>Prytuła A, van Gelder T. Clinical aspects of tacrolimus use in paediatric renal transplant recipients. Pediatr Nephrol. 2019;34(1):31-43.</Citation>
</Reference>
<Reference><Citation>Jain AB, Venkataramanan R, Eghtesad B, et al. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl. 2003;9(9):954-960.</Citation>
</Reference>
<Reference><Citation>Ehud C, Matthew D, Eric S, et al. The QT interval in patients with SARS-CoV-2 infection treated with hydroxychloroquine/azithromycin. medRxiv preprint. 2020. https://doi.org/10.1101/2020.04.02.20047050</Citation>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001714 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001714 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32400965 |texte= Coronavirus disease 2019 and transplantation: The combination of lopinavir/ritonavir and hydroxychloroquine is responsible for excessive tacrolimus trough level and unfavorable outcome. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32400965" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |